---
figid: PMC4326637__nihms621657f1
figtitle: Biology of Advanced Uveal Melanoma and Next Steps for Clinical Therapeutics
organisms:
- NA
pmcid: PMC4326637
filename: nihms621657f1.jpg
figlink: /pmc/articles/PMC4326637/figure/F1/
number: F1
caption: Multiple signaling pathways are important in uveal melanoma, but Protein
  Kinase C and MEK have been identified as points of therapeutic intervention in GNAQ/11
  mutant disease. The Phosphoinositide 3-kinase/AKT pathway and Rho/Rac/Yap pathway
  have also been identified as a potential targets for therapeutic development as
  well.
papertitle: Biology of Advanced Uveal Melanoma and Next Steps for Clinical Therapeutics.
reftext: Jason J. Luke, et al. Pigment Cell Melanoma Res. ;28(2):135-147.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9530161
figid_alias: PMC4326637__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC4326637__F1
ndex: 2c13491e-def0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4326637__nihms621657f1.html
  '@type': Dataset
  description: Multiple signaling pathways are important in uveal melanoma, but Protein
    Kinase C and MEK have been identified as points of therapeutic intervention in
    GNAQ/11 mutant disease. The Phosphoinositide 3-kinase/AKT pathway and Rho/Rac/Yap
    pathway have also been identified as a potential targets for therapeutic development
    as well.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Galphaq
  - CG17760
  - CG30054
  - Oamb
  - tRNA:Glu-CTC-1-1
  - tRNA:Glu-CTC-3-9
  - tRNA:Glu-CTC-2-2
  - tRNA:Glu-CTC-3-6
  - tRNA:Glu-CTC-3-3
  - tRNA:Glu-CTC-3-8
  - tRNA:Glu-CTC-3-4
  - tRNA:Glu-CTC-3-5
  - tRNA:Glu-CTC-3-2
  - tRNA:Glu-CTC-2-3
  - tRNA:Glu-CTC-3-1
  - tRNA:Glu-CTC-2-1
  - tRNA:Glu-CTC-3-7
  - norpA
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pten
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - trio
  - rho
  - Bx
  - Rho1
  - Lcp65Ab1
  - Rac1
  - Rac2
  - Akt
  - Mtl
  - Raf
  - bsk
  - Dsor1
  - Mtk
  - Act5C
  - Act42A
  - Act57B
  - Act79B
  - Act88F
  - Act87E
  - yki
  - Erk7
  - rl
  - Mtor
  - Tor
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - GNAQ
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MTG1
  - PTEN
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - TRIO
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT2
  - AKT3
  - MAPK8
  - MAPK9
  - MAPK10
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - YAP1
  - EPHB2
  - MAPK1
  - MAPK3
  - MTOR
  - Cancer
  - Cardiomyopathy
---
